Encounter for screening for human papillomavirus (HPV) The 2022 edition of ICD-10-CM Z11. 51 became effective on October 1, 2021.
CPT CODES 90649 HPV vaccine, types 6, 11, 16, 18 (quadrivalent), 3-dose schedule, for intramuscular use. HPV vaccine, types 16, 18, bivalent, 3 dose schedule, for intramuscular use.
Use 90472 in conjunction with 90460, 90471, or 90473. There can be only 1 first administration during a given visit. Effective for dates of service on or after October 1, 2020, encounter for immunization. Report 90461 in conjunction with 90460.
The following uses and restrictions for Human Papilloma Virus (HPV) vaccines CPT code 90649 (Gardasil®) and CPT code 90650 (Cervarix®) are effective for claims dates of service on/after Oct. 21, 2009.Jun 28, 2011
CPT® procedure code 90651, “Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV), 3 dose schedule, for intramuscular use.” This vaccine is covered under the VFC and SCHIP programs.
90471: Immunization administration for percutaneous, intra-dermal, subcutaneous or intramuscular injections, initial.Jul 26, 2021
Code Z23, which is used to identify encounters for inoculations and vaccinations, indicates that a patient is being seen to receive a prophylactic inoculation against a disease.
90734 Meningicoccal conjugate vaccine, serogoups A, C, Y and W-135 (tetravalent), for intramuscular use (Menactra).
90832 – Psychotherapy 30 minutes. 90834 – Psychotherapy 45 minutes. 90837 – Psychotherapy 60 minutes. Some health insurance companies may consider 90834 as the standard psychotherapy session.
What is the difference between GARDASIL®* and GARDASIL®9? GARDASIL®9 is a vaccine (injection/shot) that helps protect against some diseases caused by 9 types of Human Papillomavirus (HPV). GARDASIL®9 contains the same 4 HPV types (6, 11, 16, 18) as in GARDASIL®* with 5 additional HPV types (31, 33, 45, 52, 58).
CPT® Code 90620 in section: Meningococcal vaccine.
88142. Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thinlayer preparation; manual screening under physician supervision) n/a as on clinical lab fee schedule n/a n/a n/a n/a n/a 500,809 Technical component on liquid-based Pap tests, any reporting system.